Biodegradable metals

YF Zheng, XN Gu, F Witte - Materials Science and Engineering: R: Reports, 2014 - Elsevier
After decades of develo** strategies to minimize the corrosion of metallic biomaterials,
there is now an increasing interest to use corrodible metals in a number of medical device …

Coronary balloon angioplasty, stents, and scaffolds

RA Byrne, GW Stone, J Ormiston, A Kastrati - The Lancet, 2017 - thelancet.com
Since the first coronary angioplasty on Sept 16, 1977, the field of percutaneous coronary
intervention has evolved rapidly. Now marking its 40th anniversary, percutaneous coronary …

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions …

PW Serruys, B Chevalier, D Dudek, A Cequier… - The Lancet, 2015 - thelancet.com
Background Despite rapid dissemination of an everolimus-eluting bioresorbable scaffold for
treatment for coronary artery disease, no data from comparisons with its metallic stent …

[CARTE][B] Laser-tissue interactions

MH Niemz - 2007 - Springer
Welcome to a fascinating field of medical research! Welcome to this fourth edition of “Laser–
Tissue Interactions” which has meanwhile turned into the standard reference book at …

Initial and 6-Month Results of Biodegradable Poly-l-Lactic Acid Coronary Stents in Humans

H Tamai, K Igaki, E Kyo, K Kosuga, A Kawashima… - Circulation, 2000 - ahajournals.org
Background—Although metallic stents are effective in preventing acute occlusion and
reducing late restenosis after coronary angioplasty, many concerns still remain. Compared …

Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model

RS Schwartz, KC Huber, JG Murphy… - Journal of the American …, 1992 - Elsevier
Restenosis is a reparative response to arterial injury occurring with percutaneous coronary
revascularization. However, the quantitative characteristics of the relation between vessel …

A prospective randomized trial comparing sirolimus-coated balloon with paclitaxel-coated balloon in de novo small vessels

K Ninomiya, PW Serruys, A Colombo, B Reimers… - Cardiovascular …, 2023 - jacc.org
Background There are no data comparing sirolimus-coated balloons (SCBs [MagicTouch,
Concept Medical]) to paclitaxel-coated balloons (PCBs [SeQuent Please Neo, B. Braun]) for …

Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?

Y Onuma, PW Serruys - Circulation, 2011 - ahajournals.org
Gruntzig in 1977 was a huge leap forward in cardiovascular medicine and undoubtedly will
always be remembered as a revolution in the field of revascularization. However, this …

[PDF][PDF] The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

GUSTO Angiographic Investigators - New England Journal of …, 1993 - Mass Medical Soc
Background Although it is known that thrombolytic therapy improves survival after acute
myocardial infarction, it has been debated whether the speed with which coronary-artery …

Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance

A Colombo, P Hall, S Nakamura, Y Almagor, L Maiello… - Circulation, 1995 - ahajournals.org
Background The placement of stents in coronary arteries has been shown to reduce
restenosis in comparison to balloon angioplasty. However, clinical use of intracoronary …